N-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamidemethanesulfonate; 4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide Methanesulfonate; CGP 57148B; Gleevac; Glivec; Imatinib Mesilate; Imatinib Mesylate; STI 571;
Imatinib Mesylate is a fully characterized chemical compound used as a reference standard of API Imatinib. The standard offered is compliant with regulatory guidelines. Imatinib Mesylate is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 220127-57-1
Related products
4-(4-Methylpiperazinomethyl)benzoic Acid, Dihydrochloride
M.F.
M.W. 234.29 72.92
CAT# AR-B00974
CAS# 106261-49-8
N-Nitroso Imatinib EP Impurity C (N-Nitroso Piperazine)
M.F.
M.W. 508.59
CAT# AR-I03054
CAS# 2816369-80-7
